MARIA TEDTAOTAO: Open Payments
NPI 1437264546 · LYNN HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 67 payments from 18 companies in 2025. Trend: 2023 $1,255 · 2024 $1,336 · 2025 $1,408
Food & beverage: $1,348Education: $60
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $216 |
| Merck Sharp & Dohme LLC | 8 | $195 |
| PFIZER INC. | 8 | $152 |
| Lilly USA, LLC | 7 | $116 |
| AstraZeneca Pharmaceuticals LP | 6 | $114 |
| Novo Nordisk Inc | 5 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Astellas Pharma US Inc | 1 | $60 |
| Kowa Pharmaceuticals America, Inc. | 3 | $50 |
| GlaxoSmithKline, LLC. | 3 | $47 |
Products named: Kerendia, VERQUVO, MOUNJARO, PREVNAR 20, FARXIGA, CAPLYTA, ZORYVE, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
